Home › Dermatitis › Alabama › Birmingham
Dermatitis clinical trials in Birmingham, AL
6 studies for Dermatitis are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
RecruitingPhase 3
- Cahaba Dermatology & Skin Health Center, Birmingham
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
RecruitingPhase 1Healthy volunteers welcome
- Cahaba Dermatology & Skin Health Center, LLC, Birmingham
Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis
RecruitingPhase 3
- Arcutis Site 324, Birmingham
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
RecruitingPhase 3
- AllerVie Clinical Research, Birmingham
- Cahaba Dermatology & Skin Health Center, Birmingham
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
RecruitingPhase 2
- Novartis Investigative Site, Birmingham
- Novartis Investigative Site, Birmingham
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- AllerVie Clinical Research, Birmingham
- Cahaba Dermatology and Skin Health Center, Birmingham
Dermatitis trials in other cities
- Miami, FL5 studies
- Little Rock, AR4 studies
- Huntington Beach, CA4 studies
- Los Angeles, CA4 studies
- San Antonio, TX3 studies
- Santa Clarita, CA3 studies
- Fargo, ND3 studies
- Tampa, FL3 studies
- Dallas, TX3 studies
- Lewisville, TX3 studies
Other studies in Birmingham
- Cancer (all types)30 studies
- Ovarian Cancer25 studies
- Breast Cancer24 studies
- Non-Small Cell Lung Cancer23 studies
- Obesity22 studies
- Acute Myeloid Leukemia21 studies
- COPD17 studies
- Multiple Myeloma17 studies
- Cardiovascular Disease16 studies
- Endometrial Cancer16 studies
- Overweight16 studies
- Type 2 Diabetes16 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.